Stocks›Consumer Cyclical›CVS

CVS

CVS Health Corporation
NYSEResearch view

CVS Health Corporation operates in the Retail-Drug Stores And Proprietary Stores industry.

$86.46+1.48%
Oct 2 close · 1D EOD · Databento
Consumer CyclicalRetail-Drug Stores And Proprietary StoresLarge-capSEC EDGAR FY 2025-12-31

The numbers · FY2025, filed

SEC EDGAR
Market cap$110.6B
Revenue$402.1B+7.80%
Net income$1.8B
EPS, diluted$1.39−62.00%
Operating margin1.2%
Return on equity2.3%
All filed figures

Snapshot

SEC EDGAR · FY 2025-12-31
SectorConsumer Cyclical
Market Cap$110.6B
Enterprise Value$173.5B
Income$1.8B
Sales$402.1B
Book/sh$58.94
Cash/sh$6.81
Dividend TTM$2.66
Payout192%
Employees—
IPO—
Quick Ratio0.63
Current Ratio0.84
Debt/Eq0.95
EPS (ttm)$1.39
EPS this Y-62.0%
EPS past 3/5Y-24.7%
Sales past 3/5Y7.6%
EPS Y/Y TTM-62.0%
Sales Y/Y TTM7.8%
Shs Outstand1.28B
ROA0.7%
ROE2.3%
ROIC2.7%
Gross Margin—
Oper. Margin1.2%
Profit Margin0.4%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$292.1B
FY21
$322.5B
FY22
$357.8B
FY23
$372.8B
FY24
$402.1B
FY25

Operating leverage — margins

GrossOperatingNet
0%40%80%1%0%FY21FY22FY23FY24FY25
Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it
USDFY2021FY2022FY2023FY2024FY2025

Same industry

In the screener →

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.